Features include Headlines, Commentaries, Conference Coverage and Videos.
Browsing: Features
AACR 2018: Pembrolizumab reduced the risk for recurrence of stage 3 melanoma
A one-year course of 18 doses of pembrolizumab significantly reduced the risk of recurrence for…
AACR 2018: Selective inhibitor shows early promise in patients with RET-altered cancers
BLU-667, a next-generation inhibitor that selectively targets the oncogenic receptor tyrosine kinase RET, was well…
AACR 2018: CheckMate-227 meets co-primary endpoint of PFS in NSCLC
Among patients with newly diagnosed advanced non-small cell lung cancer (NSCLC) with high tumour mutational…
AACR 2018: Crizotinib yielded a high objective response rate for adult patients with ALK-positive inflammatory myofibroblastic tumour
Among patients with inoperable, advanced, or metastatic ALK-positive inflammatory myofibroblastic tumour, 50 percent were confirmed…
One Million Genomes declaration ‘a huge leap forward’ in cancer
In what will be a major boost to cancer patients across Europe, Digital Day 2018…
Personalised tumour vaccine shows promise in pilot trial
A new type of cancer vaccine has yielded promising results in an initial clinical trial…
After testicular cancer is cured, remain alert in the future
Because testicular cancer has a 95 percent cure rate, it is easier for men to…
UK parents want the HPV vaccine for their sons – new research
Sue Sherman, Keele University Human papillomavirus (HPV) is a sexually transmitted infection that causes diseases…
Certain iron supplements may influence the development of colon cancer
Two common iron compounds increase the formation of a known biomarker for cancer, according to…
Better quality of life and cancer patients’ satisfaction with a coordinating nurse
Investing in the continuity of care for lung cancer patients can bring tremendous benefits in…